Cardiovascular disease is a leading cause of mortality among TTP survivors in clinical remission

Immune-mediated thrombotic thrombocytopenic purpura (iTTP) survivors experience high rates of adverse health sequelae and increased mortality over long-term follow-up. We conducted this multicenter cohort study to evaluate long-term mortality and causes of death in iTTP survivors. Between 2003 and 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Sukumar, Senthil, Brodsky, Max, Hussain, Sarah, Yanek, Lisa, Moliterno, Alison, Brodsky, Robert, Cataland, Spero R., Chaturvedi, Shruti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864652/
https://www.ncbi.nlm.nih.gov/pubmed/34461629
http://dx.doi.org/10.1182/bloodadvances.2020004169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864652/
https://www.ncbi.nlm.nih.gov/pubmed/34461629
http://dx.doi.org/10.1182/bloodadvances.2020004169

Ejemplares similares